Fedakar Ali, Cakalagaoglu Canturk, Konukoglu Oguz, Yanartas Mehmet, Göçer Sinan, Zeybek Rahmi, Balkanay Mehmet
Kartal Kosuyolu Heart and Research Hospital, Cardiovascular Surgery Clinic, Istanbul, Turkey.
Trop Doct. 2011 Oct;41(4):227-9. doi: 10.1258/td.2011.090444. Epub 2011 Aug 30.
Antibiotic treatment, surgical intervention and postoperative antibiotic regimens are recommended for the treatment of brucella endocarditis (BE). Our clinical antibiotic regimens involve a triple antibiotic regimen for treating BE before the operation. The combination of three antibiotics is continued for at least six months and until the titres of the Wright serologic test are diminished to 1:160 levels. In this study, our aim was to evaluate the effects of combined medical and surgical treatments on survival and relapse rates in the periods of mid to late terms. We investigated 13 patients who were treated between January 1993 and June 2009. Our clinical observations led us to use a combination of rifampicin (900 mg twice a day), streptomycin (12 to 16 mg/kg/24 h intramuscularly) and doxycycline (200 mg/kg twice a day); rifampicin, tetracycline (8 mg/kg three times a day) and cotrimoxazole (15 mg/kg twice a day) or rifampicin, doxycycline and cotrimoxazole regimen for treating BE before the operation. This treatment should be continued for at least six months after surgery in order to prevent relapses.
推荐采用抗生素治疗、手术干预及术后抗生素方案来治疗布鲁氏菌性心内膜炎(BE)。我们的临床抗生素方案包括术前采用三联抗生素方案治疗BE。三种抗生素联合使用至少持续6个月,直至Wright血清学检测滴度降至1:160水平。在本研究中,我们的目的是评估药物与手术联合治疗对中晚期生存率和复发率的影响。我们调查了1993年1月至2009年6月期间接受治疗的13例患者。我们的临床观察结果使我们在术前采用利福平(每日两次,每次900 mg)、链霉素(12至16 mg/kg/24小时,肌内注射)和强力霉素(每日两次,每次200 mg/kg)联合使用;或利福平、四环素(每日三次,每次8 mg/kg)和复方新诺明(每日两次,每次15 mg/kg);或利福平、强力霉素和复方新诺明方案来治疗BE。术后应继续这种治疗至少6个月,以防止复发。